Results 11 to 20 of about 1,095,380 (327)

The Impact of Clinical and Pathological Features on Intraductal Papillary Mucinous Neoplasm Recurrence After Surgical Resection: Long-Term Follow-Up Analysis. [PDF]

open access: yesAnn Surg, 2022
Objective: This study aimed to identify risk factors for recurrence after pancreatic resection for intraductal papillary mucinous neoplasm (IPMN). Summary Background Data: Long-term follow-up data on recurrence after surgical resection for IPMN are ...
Pflüger MJ   +17 more
europepmc   +2 more sources

Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas [PDF]

open access: bronzeGastroenterology, 2002
BACKGROUND & AIMS The aim of this study was to determine recurrence and long-term survival after resection of pancreatic intraductal papillary mucinous neoplasm and to correlate recurrence and survival with histology, extent of resection, and duration of
Suresh T. Chari   +12 more
openalex   +2 more sources

Increased neutrophil–lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification

open access: yesBMC Surgery, 2021
Background The prognostic values of inflammation-based markers in well-differentiated pancreatic neuroendocrine neoplasms, diagnosed according to the new 2017 World Health Organization classification, have remained unclear.
T. Miura   +17 more
semanticscholar   +1 more source

Prediction of Recurrence Risk in Solid Pseudopapillary Neoplasm of the Pancreas: Single-Institution Experience

open access: yesCureus, 2021
Background: Solid pseudopapillary neoplasm (SPN) of the pancreas is a low-grade malignant neoplasm with unpredictable behavior. Factors associated with recurrence were not conclusively identified.
Jalaj Rathi   +5 more
semanticscholar   +1 more source

Granular Cell Ameloblastoma: A Rare Case Report and Literature Review [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Ameloblastomas are rare, benign, aggressive neoplasms of odontogenic epithelial origin. Among the various types of ameloblastomas, granular cell ameloblastoma is rare and accounts for less than 5% of the total.
Samiha Jameel Ahmed Khan   +4 more
doaj   +1 more source

A misdiagnosed case of blastic plasmacytoid dendritic cell neoplasm experiencing multiple recurrences who underwent allogeneic stem cell transplantation: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Blastic plasmacytoid dendritic cell neoplasm represents a rare type of hematologic malignancy that often manifests itself through various skin lesions. It commonly affects the elderly male population.
Fateme Salemi   +5 more
doaj   +1 more source

Superficial Acral Fibromyxoma involving the nail's apparatus. Case report and literature review [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2014
Superficial Acral Fibromyxoma is a rare tumor of soft tissues. It is a relatively new entity described in 2001 by Fetsch et al. It probably represents a fibrohistiocytic tumor with less than 170 described cases.
Ana Marquez Garcia   +4 more
doaj   +1 more source

Radiomics and Prostate MRI: Current Role and Future Applications

open access: yesJournal of Imaging, 2021
Multiparametric prostate magnetic resonance imaging (mpMRI) is widely used as a triage test for men at a risk of prostate cancer. However, the traditional role of mpMRI was confined to prostate cancer staging. Radiomics is the quantitative extraction and
Giuseppe Cutaia   +13 more
doaj   +1 more source

Cytomegalovirus Infection Mimicking Recurrence of Malignant Lymphoma: A Case Report

open access: yesClinical Pediatric Hematology-Oncology, 2021
When a patient with malignant lymphoma develops new lymph node enlargement, a recurrence of lymphoma is usually suspected first. However, painless and rapid lymph node enlargement, a manifestation of non-Hodgkin’s lymphoma, could also be due to other ...
Sae-Mee Park   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy